Martin Ignacio Zapata Laguado, Medical oncologist and internal medicine physician at Instituto Nacional de Cancerologia, shared on X:
“Negative trial in newly diagnosed glioblastoma at ESMO26. ‘
Adding trotabresib to standard RT/TMZ failed to improve PFS. Late curve separation raises questions about treatment exposure.
Amazing presentation”
You may also be interested in:
GPNMB CAR-T: Targeting Glioblastoma and Its Immune Microenvironment
